ID: ALA158113

Max Phase: Preclinical

Molecular Formula: C11H11ClN4

Molecular Weight: 234.69

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1nc(Cl)cc(NCc2ccccc2)n1

Standard InChI:  InChI=1S/C11H11ClN4/c12-9-6-10(16-11(13)15-9)14-7-8-4-2-1-3-5-8/h1-6H,7H2,(H3,13,14,15,16)

Standard InChI Key:  GXNJAZPAQIPYMJ-UHFFFAOYSA-N

Associated Targets(non-human)

DNA topoisomerase III 145 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 234.69Molecular Weight (Monoisotopic): 234.0672AlogP: 2.32#Rotatable Bonds: 3
Polar Surface Area: 63.83Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 5.10CX LogP: 2.52CX LogD: 2.51
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.80Np Likeness Score: -1.55

References

1. Trantolo DJ, Wright GE, Brown NC..  (1986)  Inhibitors of Bacillus subtilis DNA polymerase III. Influence of modifications in the pyrimidine ring of anilino- and (benzylamino)pyrimidines.,  29  (5): [PMID:3084785] [10.1021/jm00155a016]

Source